Yea - the population with RA is akin to Baby Boomers. The autoimmune universe is not a normal distribution and as far as I’m aware, we are the biggest group by far. So we are going to get the research money and the new drugs. It is a side benefit that people with other autoimmune diseases frequently can get benefit from one or more of the same drugs. But too many seem relegated to the corners of treatment options.